Immunotec Inc (IMMTF) 0.1940 $IMMTF
Immunotec Reports Issuance of Options
Marketwired - Wed Jun 17, 5:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced that pursuant to the Immunotec Stock Option Plan, a group of directors, officers, managers and a consultant were granted options entitling them to acquire, in the aggregate, up to 1,000,000 common shares of the Company (the "Shares". The exercise price of such options was established at $0.30, which is the closing price of the Shares on the TSX Venture Exchange the day before their issuance. These options will vest over a three-year period, with one-third (1/3) which will vest on each of the first, second and third anniversaries of the date of the grant. Each option is exercisable, once vested, for a period of five years from the date of grant.
IMM.VN: 0.250 (unch)
Immunotec Reports Second Quarter Results
Marketwired - Fri Jun 12, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its consolidated financial results for the second quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.250 (unch)
Immunocal(R) First to be Granted Strength and Performance Claim for a Stand-Alone Whey Protein by Health Canada
Marketwired - Tue May 12, 8:03AM CDT
Immunotec Inc. (TSX VENTURE: IMM) a direct-to-consumer company and leader in the nutritional industry (the "Company" or "Immunotec" announced today that Health Canada has granted a new health claim specific to Immunocal's ability to help increase muscle strength and enhance performance when combined with regular exercise.
IMM.VN: 0.250 (unch)
Immunotec Ranks No. 97 in Sixth Annual DSN Global 100
Marketwired - Mon Apr 20, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry has been ranked 97th on the Direct Selling News sixth annual DSN Global 100 list. This list is an exclusive ranking of the top revenue-generating companies in the direct selling industry worldwide.
IMM.VN: 0.250 (unch)
Herbalife: The Eve Of Destruction
Rogier van Vlissingen - at Seeking Alpha - Thu Mar 26, 11:14AM CDT
HLF: 51.41 (+1.17), AVP: 5.90 (-0.07), NUS: 41.62 (-0.19), LFVN: 0.54 (unch)
Immunotec Reports Results of its Annual General and Special Meeting of Shareholders
Marketwired - Fri Mar 20, 3:19PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today reported the results of its Annual General and Special Meeting of Shareholders held on March 17, 2015 ("AGM". During the AGM, all current directors of the Company were re-elected, PricewaterhouseCoopers LLP was reappointed as the Company's auditor and the new Management Incentive Plan ("MIP" announced on February 18, 2015 was approved by disinterested shareholders. Three million common shares of the Company (the "Shares" are reserved and authorized for future issuance under this MIP. The full text of the MIP appears in the Company's Management Proxy Circular filed on February 19, 2015 on SEDAR and may be consulted at www.sedar.com.
IMM.VN: 0.250 (unch)
Immunotec Reports First Quarter Results
Marketwired - Tue Mar 17, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its consolidated financial results for the first quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.250 (unch)
Immunotec Announces Proposed Management Incentive Plan
Marketwired - Wed Feb 18, 3:49PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct- to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced the terms of its new Management Incentive Plan ("MIP". This MIP will be submitted to the Company's shareholders for approval at the upcoming Annual and Special Meeting of Shareholders to be held on March 17, 2015.
IMM.VN: 0.250 (unch)
Immunotec Is Not Immune To Taxes
Duane Bair - at Seeking Alpha - Thu Feb 05, 7:23AM CST
Immunotec Reports 2014 Year-End Results
Marketwired - Mon Jan 26, 4:11PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its year-end consolidated financial results for Fiscal 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.250 (unch)
New Study Demonstrates Immunocal(R) Supplementation Increases Muscle Strength in Elderly Adults
Marketwired - Thu Nov 27, 3:03PM CST
Immunotec Inc. (TSX VENTURE: IM) a direct-to-consumer company, a leader in the nutritional industry (the "Company" or "Immunotec" and Institut de recherches cliniques de Montreal (IRCM) are pleased to announce important findings from this double-blind-randomized controlled study in elderly adults between the ages of 65 and 88. The results show that Immunocal(R) with statistical significance imparts a performance benefit of approximately 10 per cent in muscle strength. This is very relevant for healthy aging, as the process is typically associated with a decrease in muscle strength that may contribute to disability in old age and to loss of quality of life.
IMM.VN: 0.250 (unch)
Immunotec Reports Issuance of Options
Marketwired - Wed Jun 17, 5:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced that pursuant to the Immunotec Stock Option Plan, a group of directors, officers, managers and a consultant were granted options entitling them to acquire, in the aggregate, up to 1,000,000 common shares of the Company (the "Shares". The exercise price of such options was established at $0.30, which is the closing price of the Shares on the TSX Venture Exchange the day before their issuance. These options will vest over a three-year period, with one-third (1/3) which will vest on each of the first, second and third anniversaries of the date of the grant. Each option is exercisable, once vested, for a period of five years from the date of grant. IMM.VN: 0.250 (unch)
Immunotec Reports Second Quarter Results
Marketwired - Fri Jun 12, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its consolidated financial results for the second quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.250 (unch)
Immunocal(R) First to be Granted Strength and Performance Claim for a Stand-Alone Whey Protein by Health Canada
Marketwired - Tue May 12, 8:03AM CDT
Immunotec Inc. (TSX VENTURE: IMM) a direct-to-consumer company and leader in the nutritional industry (the "Company" or "Immunotec"
announced today that Health Canada has granted a new health claim specific to Immunocal's ability to help increase muscle strength and enhance performance when combined with regular exercise. IMM.VN: 0.250 (unch)
Immunotec Ranks No. 97 in Sixth Annual DSN Global 100
Marketwired - Mon Apr 20, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry has been ranked 97th on the Direct Selling News sixth annual DSN Global 100 list. This list is an exclusive ranking of the top revenue-generating companies in the direct selling industry worldwide.
IMM.VN: 0.250 (unch)
Herbalife: The Eve Of Destruction
Rogier van Vlissingen - at Seeking Alpha - Thu Mar 26, 11:14AM CDT
HLF: 51.41 (+1.17), AVP: 5.90 (-0.07), NUS: 41.62 (-0.19), LFVN: 0.54 (unch)
Immunotec Reports Results of its Annual General and Special Meeting of Shareholders
Marketwired - Fri Mar 20, 3:19PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today reported the results of its Annual General and Special Meeting of Shareholders held on March 17, 2015 ("AGM". During the AGM, all current directors of the Company were re-elected, PricewaterhouseCoopers LLP was reappointed as the Company's auditor and the new Management Incentive Plan ("MIP" announced on February 18, 2015 was approved by disinterested shareholders. Three million common shares of the Company (the "Shares" are reserved and authorized for future issuance under this MIP. The full text of the MIP appears in the Company's Management Proxy Circular filed on February 19, 2015 on SEDAR and may be consulted at www.sedar.com. IMM.VN: 0.250 (unch)
Immunotec Reports First Quarter Results
Marketwired - Tue Mar 17, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its consolidated financial results for the first quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.250 (unch)
Immunotec Announces Proposed Management Incentive Plan
Marketwired - Wed Feb 18, 3:49PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct- to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced the terms of its new Management Incentive Plan ("MIP". This MIP will be submitted to the Company's shareholders for approval at the upcoming Annual and Special Meeting of Shareholders to be held on March 17, 2015. IMM.VN: 0.250 (unch)
Immunotec Is Not Immune To Taxes
Duane Bair - at Seeking Alpha - Thu Feb 05, 7:23AM CST
Immunotec Reports 2014 Year-End Results
Marketwired - Mon Jan 26, 4:11PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its year-end consolidated financial results for Fiscal 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.250 (unch)
New Study Demonstrates Immunocal(R) Supplementation Increases Muscle Strength in Elderly Adults
Marketwired - Thu Nov 27, 3:03PM CST
Immunotec Inc. (TSX VENTURE: IM) a direct-to-consumer company, a leader in the nutritional industry (the "Company" or "Immunotec"
and Institut de recherches cliniques de Montreal (IRCM) are pleased to announce important findings from this double-blind-randomized controlled study in elderly adults between the ages of 65 and 88. The results show that Immunocal(R) with statistical significance imparts a performance benefit of approximately 10 per cent in muscle strength. This is very relevant for healthy aging, as the process is typically associated with a decrease in muscle strength that may contribute to disability in old age and to loss of quality of life. IMM.VN: 0.250 (unch)
